From: COVID-19-associated mucormycosis: an update of anesthetic management
 | Days | Number |
---|---|---|
Extubation in operating room | Yes | 52 |
No | 5 | |
Shifted to postoperative ward | Â | 44 |
Shifted to ICU | Â | 13 |
Postoperative ICU stay duration (days) | 2 | 7 |
3 | 2 | |
4 | 2 | |
≥ 5–10 | 2 | |
Postoperative ventilator duration (days) | 1 | 4 |
≥ 4–6 | 1 | |
Hospital stay ward (days) | ≥ 15 | 4 |
≥ 20 | 5 | |
≥ 25 | 30 | |
≥ 30–40 | 3 | |
Discharged | 15–40 | 42 |
Expired | 3–15 | 15/57 |
Mortality rate | Â | 26.31% |
Intravenous amphotericin B continue, day | 14 (8–45) | 57 |